Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. S-1/A Offering Registration Statement
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CERTNAS Other Certification by the Nasdaq Stock Market
  17. 8-A12B Other Registration of Securities
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. S-1/A Offering Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 39 of 40 · 789 filings